N/A
Completed N=215
Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
Source: ClinicalTrials.gov NCT01952600 ↗Enrolled (actual)
215
Serious AEs
0.0%
Results posted
Aug 2016
Primary outcomePrimary: Factors That Are Most Important to Patients — 98; 93; 97; 100 % of patients
Summary
The EPOCH-RRT study seeks to fill knowledge gaps by gaining more understanding of chronic kidney disease (CKD) patients' priorities; assessing the comparative benefits of hemodialysis (HD) versus peritoneal dialysis (PD), with respect to these priorities; and providing tailored information to assist patients with identifying the best dialysis modality fit for their own unique circumstances and perspectives.
The outcomes most relevant to patients ("patient-centered") extend beyond those traditionally assessed in clinical research, with the relative importance varying across patient groups. A tailored decision aid based on these findings can improve patient decision-making processes regarding choice of dialysis modality.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Factors That Are Most Important to Patients |
98; 93; 97; 100; 89; 92 | — |
Eligibility Criteria
Inclusion Criteria
- Individuals 18 years of age or older.
- Individuals with advanced chronic kidney disease or on dialysis (in-center, hemodialysis, or peritoneal dialysis) for at least three months.
Exclusion Criteria
- Individuals under 18 years of age.
- Individuals unable to provide informed consent.
- Individuals who do not have chronic kidney disease.
Data sourced from ClinicalTrials.gov (NCT01952600). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.